|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/573 | |
| A61N 1/04 | |||
| A61K 9/00 | |||
| A61P 27/02 |
| (11) | Number of the document | 2249921 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09714994.2 |
| Date of filing the European patent application | 2009-02-24 | |
| (97) | Date of publication of the European application | 2010-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/034977 |
| Date | 2009-02-24 |
| (87) | Number | WO 2009/108626 |
| Date | 2009-09-03 |
| (30) | Number | Date | Country code |
| 31267 P | 2008-02-25 | US | |
| 47950 P | 2008-04-25 | US |
| (72) |
JAFFE, Mike, US
COOK, Gary, US
CALIAS, Perry, US
PATANE, Mike, US
|
| (73) |
Eyegate Pharmaceuticals, Inc.,
100 Beaver Street, Waltham, MA 02453,
US
|
| (54) | ENHANCED DELIVERY OF DEXAMETHASONE PHOSPHATE TO OCULAR TISSUES THROUGH IONTOPHORESIS |
| ENHANCED DELIVERY OF DEXAMETHASONE PHOSPHATE TO OCULAR TISSUES THROUGH IONTOPHORESIS |